Document:

<PAGE>

                                                                   Exhibit 10.20

                              EMPLOYMENT AGREEMENT

         EMPLOYMENT AGREEMENT ("Agreement") made and entered into as of April
15, 1999 (the "Effective Date"), by and between GENAISSANCE PHARMACEUTICALS,
INC. (the "Corporation"), a Delaware corporation with its principal office at 5
Science Park, New Haven, Connecticut, 06511, and GERALD F. VOVIS, PH.D.
("Executive"), an individual who resides at 98 Prendiville Way, Marlborough,
Massachusetts, 01752-1740.

         WHEREAS, the Corporation desires to employ Executive, and Executive
desires to accept employment with the Corporation, subject to the terms and
conditions hereinafter set forth.

         NOW, THEREFORE, in consideration of the mutual covenants and agreements
contained herein, and other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties agree as follows:

         1.   EMPLOYMENT. Executive shall be employed as an officer in the
capacity of Senior Vice President, Genomics ("SVP") of the Corporation during
the term of this Agreement, and Executive hereby accepts such employment, on the
terms and conditions hereinafter set forth. Executive represents that his
employment by the Corporation pursuant to this Agreement does not violate any
agreement, covenant or obligation to which he is a party or by which he is
bound.

         2.   DUTIES. During the term of this Agreement, Executive shall perform
all duties, consistent with his position as SVP in order to advance the
Corporation's genomics technology and related business efforts, assigned or
delegated to him by the Chief Executive Officer of the Corporation or his
delegate (the "CEO"), and normally associated with the position of SVP,
including, without limitation, managing the Corporation's genomics team,
addressing strategic and tactical business decisions of the Corporation with
other senior managers, and acting as liaison with the Corporation's Scientific
Advisory Board. He shall devote all of his full business time and best efforts
to the advancement of the interests and business of the Corporation except that
he shall be permitted from time to time to fulfill his responsibilities as a
member of the Scientific Advisory Board of Westminster College in New
Willmington, PA, so long as such responsibilities do not interfere with his
performance of his duties to the Corporation.

         3.   TERM. The term of Executive's employment under this Agreement
shall begin on the Effective Date, and shall expire at the close of business on
April 15, 2003, unless earlier terminated as provided in this Agreement (the
"Initial Term"). Upon expiration of the Initial Term, and each subsequent term
or extension thereof, this Agreement shall automatically be extended for an
additional term of one (1) year, unless Executive or the Corporation shall have
notified the other of his or its election to terminate this Agreement not later
than one hundred eighty (180) days prior to the end of such subsequent term or
extension thereof (the "Initial Term", together with any extensions, until
termination in accordance herewith, shall be referred

<PAGE>

to herein as the "Employment Term"). If the Executive continues in the full-time
employ of the Corporation after the end of the Employment Term (it being
expressly understood and agreed that the Corporation does not now, nor hereafter
shall have, any obligation to continue the Executive in its employ, whether or
not on a full-time basis, after the Employment Term ends), then the Executive's
continued employment by the Corporation shall, notwithstanding anything to the
contrary expressed or implied herein, be terminable by the Corporation at will.

         4.   COMPENSATION. As compensation for the services to be rendered by
Executive to the Corporation pursuant to this Agreement, the Corporation shall
pay Executive and provide Executive with the following compensation and benefits
which Executive agrees to accept in full satisfaction for his services:

              a.   BASE SALARY. The Corporation shall pay Executive a base
         salary, payable in equal installments at such payment intervals as are
         the usual custom of the Corporation, but not less often than monthly,
         at an annual rate of $185,000, less such deductions or amounts to be
         withheld as shall be required by applicable law (the "Base Salary").
         The Base Salary shall be reviewed annually by the CEO and shall be
         increased (but not decreased), if at all, (effective as of each
         successive anniversary of the Effective Date) by such amount, if any,
         as the CEO, in his sole discretion, shall determine.

              b.   BONUSES. Beginning in the year 2000, during the first quarter
         of each of the Corporation's fiscal years during the Employment Term,
         the Corporation shall pay Executive a bonus (an "Incentive Bonus")
         equal to such amount as shall be determined by the CEO in his sole
         discretion based upon Executive's achievements in meeting his
         performance goals and those of the Corporation for its most recently
         ended fiscal year. For the fiscal year ending December 31, 1999, such
         goals shall be established by June 1, 1999. Thereafter, such goals
         shall be established in the first quarter of each fiscal year after the
         commencement of the Employment Term. Each Incentive Bonus may be
         payable in cash and/or stock options as determined by the CEO.

              c.   BENEFITS.

                   (i)       Executive shall be entitled to participate, to the
              extent he is eligible, in all group insurance programs, health,
              medical, dental, and disability plans, and other employee benefit
              plans (including, without limitation, the Corporation's 401(k)
              plan) which the Corporation may hereafter in its sole and absolute
              discretion make available generally to its senior management
              (other than any incentive compensation or equity ownership plan,
              for which he shall be eligible at the discretion of the CEO), but
              the Corporation shall not be required to establish or maintain any
              such program or plan.

                   (ii)      Executive shall be entitled to three (3) weeks paid
              vacation during each calendar year. Such vacation may be taken at
              such time or times as is reasonably consistent with the
              Corporation's vacation policies and the performance by Executive
              of his duties and responsibilities hereunder.

                                      -2-

<PAGE>

                   (iii)     Executive shall be entitled to participate in the
              Corporation's 1993 Stock Option Plan (the "Plan") and the
              Corporation shall use its best efforts to cause the board of
              directors of the Corporation (the "Board") or the applicable
              committee of the Board to grant Executive an option pursuant to
              the terms of the Plan, having a ten-year term, to purchase 100,000
              shares of the Corporation's common stock at an exercise price per
              share equal to $3.00 (the "Option"), which Option shall be subject
              to the provisions set forth in a separate agreement embodying the
              grant of the Option and shall be in the form attached hereto as
              Exhibit A. In addition to the foregoing, Executive shall be
              entitled to participate in any program authorized by the Board
              which grants additional stock options by the Corporation to the
              founders of the Corporation, Gualberto Ruano, M.D., Ph.D. and
              Kevin L. Rakin (the "Founders"), under the following
              circumstances: (A) such program is established in connection with
              any equity financing of the Corporation that occurs after the
              commencement of the Employment Term and prior to an initial
              registered public offering of the Corporation's stock, and (B)
              such equity financing results in a dilution of the existing stock
              options held by the Founders or Executive. In addition, Executive
              shall be eligible to participate in the Plan with respect to his
              future performance as a senior executive of the Corporation.

                   (iv)      The Corporation shall, during the Employment Term,
              pay the premiums or a portion thereof (as specified hereafter) for
              a $1,000,000 policy of term life insurance insuring the life of
              Executive (subject to his meeting the insurability requirements of
              the insurer). The Corporation shall pay the premiums for such
              insurance policy up to the cost charged by the insurer to insure a
              healthy 56 year old male non-smoker. Executive shall be the owner
              of such policy and entitled to all of the rights of ownership
              including designation of the beneficiary thereof.

                   (v)       Subject to reasonable guidelines adopted by the
              Board, throughout the Employment Term, the Corporation shall pay
              the costs of dues for membership in at least one professional
              organization whose activities are related to the business of the
              Corporation.

                   (vi)      The Corporation shall provide Executive with a
              policy of long-term disability insurance with reasonable
              coverages, which shall include the payment of benefits equal to at
              least 60% of Executive's Base Salary during the disability
              coverage period, and the Corporation shall pay the premiums or a
              portion thereof (as specified hereafter) for such disability
              insurance policy up to the cost charged by the insurer to insure a
              healthy 56 year old male non-smoker.

                   (vii)     The Corporation, at its expense, shall pay or
              reimburse Executive for all reasonable moving expenses
              attributable to the relocation of the Executive from Marlborough,
              Massachusetts to Connecticut. At or about the commencement of the
              Employment Term, the Corporation, at its expense, shall

                                      -3-

<PAGE>

              provide Executive with a furnished apartment or executive suite in
              the New Haven area until the Executive and his family relocate.

              d.   SEVERANCE BENEFIT. If the Employment Term expires as a result
         of either (i) the Executive terminating his employment pursuant to
         Section 9(f) hereof, or (ii) the Corporation terminating Executive's
         employment pursuant to Section 9(d) hereof, then upon the expiration of
         the Employment Term, the Corporation shall be obligated to pay
         Executive the applicable amounts specified in Section 10.

         5.   BUSINESS EXPENSES. The Corporation shall pay or reimburse
Executive for the reasonable and necessary business expenses of Executive
incurred in the performance of his duties hereunder, subject to reasonable
documentation thereof and the reasonable rules and regulations of the
Corporation relating thereto.

         6.   COVENANTS AGAINST COMPETITION.

              a.   In view of the unique value to the Corporation of the
         services of Executive, and as a material inducement to the Corporation
         to enter into this Agreement and to pay to Executive the compensation
         and benefits set forth in this Agreement, Executive covenants and
         agrees that during Executive's employment and for a period of six (6)
         months after he ceases to be employed by the Corporation if his
         employment ends prior to the expiration of the Employment Term, he will
         not, except as otherwise authorized by this Agreement, compete in the
         field of pharmacogenomics with the Corporation or any affiliate of the
         Corporation, solicit the Corporation's customers or the customers of
         any of its affiliates in the field of pharmacogenomics, or directly or
         indirectly solicit for employment any of the Corporation's employees.

              b.   For the purposes of this Agreement:

                   (i)       The term "compete" means engaging in the same or
              any similar business as the Corporation or any of its affiliates
              in any manner whatsoever, including without limitation as a
              proprietor, partner, investor, shareholder, member, director,
              officer, employee, consultant, independent contractor or
              otherwise, within any geographic area in which the Corporation's
              products are offered or distributed;

                   (ii)      The term "affiliate", when used in reference to any
              Person (as hereinafter defined), means any other Person that
              directly or indirectly through one or more intermediaries
              controls, is controlled by, or is under common control with the
              first such Person; and

                   (iii)     The term "customers" means all Persons to whom the
              Corporation or any of its affiliates has provided any product or
              service, whether or not for compensation, within a period of two
              (2) years prior to the time Executive ceases to be employed by the
              Corporation.

                                      -4-

<PAGE>

                   (iv)      The term "Person" means any natural person,
              corporation, limited liability company, partnership of any type,
              proprietorship, other business organization, trust, union,
              association or governmental body.

              c.   None of the provisions of this Section 6 shall prohibit
         Executive from investing in securities listed on a national securities
         exchange or actively traded over-the-counter so long as such
         investments are not greater than five percent (5%) of the outstanding
         securities of any issuer of the same class or issue.

         7.   REASONABLENESS OF RESTRICTIONS.

              a.   Executive has carefully read and considered the provisions of
         Section 6, and, having done so, agrees that:

                   (i)       The restrictions set forth in Section 6, including
              but not limited to the time period, scope and geographical area of
              restriction, are fair and reasonable and are reasonably required
              for the protection of the good will and other legitimate business
              interests of the Corporation and its affiliates, officers,
              directors, shareholders, and other employees;

                   (ii)      Executive has received, or is entitled to receive
              pursuant to the provisions of this Agreement, adequate
              consideration for such obligations; and

                   (iii)     Such obligations do not prevent Executive from
              earning a livelihood.

              b.   If, notwithstanding the foregoing, any of the provisions of
         Section 6 shall be held to be invalid or unenforceable, the remaining
         provisions thereof shall nevertheless continue to be valid and
         enforceable as though the invalid and unenforceable parts had not been
         included therein. If any provision of Section 6 relating to the time
         period and/or the areas of restriction and/or related aspects shall be
         declared by a court of competent jurisdiction to exceed the maximum
         restrictiveness such court deems reasonable and enforceable, the time
         period and/or areas of restriction and/or related aspects deemed
         reasonable and enforceable by the court shall become and thereafter be
         the maximum restriction in such regard, and the restriction shall
         remain enforceable to the fullest extent deemed reasonable by such
         court.

         8.   REMEDIES FOR BREACH OF EXECUTIVE'S COVENANT OF NON-COMPETITION.
Executive recognizes and agrees that the Corporation would suffer irreparable
harm due to any breach of Section 6 and that the Corporation's remedy at law for
any such breach would be inadequate, and he agrees that, for breach of such
provisions, the Corporation shall, in addition to such other remedies as may be
available to it at law or in equity or as provided in this Agreement, be
entitled to injunctive relief and to enforce its rights by an action for
specific performance.

         9.   TERMINATION.

                                      -5-

<PAGE>

              a.   In the event that Executive dies during the Employment Term,
         this Agreement shall terminate upon his death, upon which event
         Executive's legal representatives shall be entitled to receive, and the
         Corporation shall pay or cause to be paid to Executive's legal
         representatives, any Base Salary and other compensation or benefits
         accrued but as yet unpaid on the date of Executive's death.

              b.   If during the Employment Term, Executive is prevented from
         performing the duties or fulfilling responsibilities of his employment
         under this Agreement by reason of any incapacity or disability for a
         continuous period of six (6) months, as determined by an independent
         qualified physician selected by the Corporation and reasonably
         acceptable to Executive (or his representative), then the Corporation
         may, upon thirty (30) days prior written notice to Executive, terminate
         Executive's employment hereunder, but Executive shall continue to be
         eligible to receive any benefits to which he may be entitled under the
         terms of any disability plan or insurance policy maintained by the
         Corporation for its employees generally or for Executive specifically.
         In the event of such incapacity or disability, the Corporation shall
         continue to pay full compensation to Executive in accordance with the
         terms of this Agreement until the date of such termination, less any
         amounts received by the Executive under any disability plan maintained
         by the Corporation.

              c.   The Corporation may, upon written notice to Executive,
         terminate Executive's employment hereunder For Cause. For purposes of
         this Agreement, the term "For Cause" shall mean:

                   (i)       A willful and material breach by Executive of his
              duties hereunder;

                   (ii)      Executive's conviction of any felony, or of a
              lesser crime having as its predicate element fraud, dishonesty or
              misappropriation of property of the Corporation;

                   (iii)     Executive's engaging in bad faith or gross
              negligence in the performance of his duties under this Agreement
              as determined in good faith by the Board;

                   (iv)      Executive's engaging in chronic alcoholism, drug
              addiction or substance abuse which has interfered with the
              performance of his duties under this Agreement; and/or

                   (v)       Executive's perpetration of any act or omission
              which submits the Corporation to criminal liability.

              In the event of termination For Cause of Executive's employment,
Executive's right to receive compensation and other benefits hereunder (other
than any Base Salary accrued but as yet unpaid on the effective date of such
termination) shall terminate on the effective date of such termination, and
Executive shall not be entitled to any severance payments or benefits pursuant
to Section 10.

                                      -6-

<PAGE>

              d.   The Corporation may, at any time, for reason other than For
         Cause, terminate Executive's employment upon at least thirty (30) days
         written notice to Executive. In the event of such termination for
         reason other than For Cause, the Corporation shall be obligated to pay
         Executive the severance payments specified in Section 10.

              e.   Executive may, at his option, upon ninety (90) days prior
         written notice to the Corporation, terminate his employment hereunder.
         In the event of a voluntary termination of his employment by the
         Executive pursuant to this Section 9(e), Executive's rights to receive
         compensation and other benefits (other than any Base Salary accrued but
         as yet unpaid on the effective date of such termination) shall
         terminate on the effective date of such termination, and Executive
         shall not be entitled to any severance payments pursuant to Section 10.

              f.   Executive may, at his option, upon at least fifteen (15) days
         written notice to the Corporation, terminate his employment hereunder,
         if the Corporation, without Executive's express written consent, (i)
         removes him as an officer of the Corporation, (ii) demotes him from
         SVP, (iii) assigns him duties materially inconsistent with the position
         and/or duties described in Sections 1 or 2, (iv) diminishes his
         responsibilities described in Sections 1 or 2, (v) fails to grant the
         options referred to in Section 4(c)(iii) prior to August 15, 1999, (vi)
         breaches any material obligations to Executive under this Agreement, or
         (vii) hereafter fails to afford the Executive anti-dilution protection
         in respect of Corporation stock and/or options held by the Executive
         from time to time proportionate to that afforded to each of the
         Founders in respect of Corporation stock and/or options held by them,
         respectively, from time to time, in connection with any equity
         financing effected prior to the initial registered public offering of
         the Corporation's stock. Upon any termination by Executive under this
         Section 9(f) the Corporation shall be obligated to pay Executive the
         severance payments specified in Section 10.

              g.   In the event of termination or expiration of Executive's
         employment other than for death, Executive shall resign from all
         positions held in the Corporation, including without limitation any
         position as a director, officer, agent, trustee or consultant of the
         Corporation or any affiliate of the Corporation.

         10.  SEVERANCE PAYMENTS. If the Corporation terminates Executive's
employment pursuant to Section 9(d) or if Executive terminates his employment
pursuant to Section 9(f), the parties recognize and agree that actual damages
due Executive would be difficult if not impossible to ascertain and agree that,
in lieu of any other rights to which Executive may be entitled (but not in lieu
of any rights or remedies that Executive may have in respect of tortious conduct
on the part of the Corporation or in respect of any violation by the Corporation
of any employment practice, employment discrimination, age discrimination or
civil rights law or regulation applicable to the Executive), the Corporation
shall pay Executive, as severance pay or as liquidated damages, or both,
Executive's Base Salary, as in effect at the time of such termination or
expiration for a period of six (6) calendar months following the date of such
termination or expiration, such payments to be made in the same manner in which
such salary

                                      -7-

<PAGE>

payments were made to Executive immediately prior to the date of such
termination or expiration.

         11.  WAIVER. A party's failure to insist on compliance or enforcement
of any provision of this Agreement shall not affect the validity or
enforceability or constitute a waiver of future enforcement of that provision or
of any other provision of this Agreement by that party or any other party.

         12.  GOVERNING LAW. This Agreement shall in all respects be subject to,
and governed by, the laws of the State of Connecticut.

         13.  SEVERABILITY. The invalidity or unenforceability of any provision
in the Agreement shall not in any way affect the validity or enforceability of
any other provision and this Agreement shall be construed in all respects as if
such invalid or unenforceable provision had never been in the Agreement.

         14.  NOTICE. Any and all notices required or permitted herein shall be
in writing and shall be deemed to have been duly given (a) when delivered if
delivered personally, (b) on the fifth day following the date of deposit in the
United States mail if sent first class, postage prepaid, by registered or
certified mail, or (c) one day after delivery to a nationally recognized
overnight courier service. The parties' respective addresses for such notices
shall be those set forth following their respective signatures below, or such
other address or addresses as either party may hereafter designate in writing to
the other.

         15.  ASSIGNMENT. This Agreement, together with any amendments hereto,
shall be binding upon and shall inure to the benefit of the parties hereto and
their respective successors, assigns, heirs, executors, and legal and personal
representatives, except that the rights and benefits of Executive under this
Agreement may not be assigned without the prior written consent of the
Corporation. Without limiting the generality of the foregoing, this Agreement
shall be binding upon and inure to the benefit of any corporation with which or
into which the Corporation or its successors may be merged or which may succeed
to its assets or business.

         16.  AMENDMENTS. This Agreement may be amended at any time by mutual
consent of the parties hereto, with any such amendment to be invalid unless in
writing and signed by the Corporation and Executive.

         17.  ENTIRE AGREEMENT. This Agreement and the agreements concerning
stock option grants and confidentiality and non-disclosure executed in
connection herewith contain the entire agreement and understanding by and
between Executive and the Corporation with respect to the employment of
Executive and supersede all existing agreements between the Corporation and
Executive with respect to such employment. No representations, promises,
agreements, or understandings, written or oral, relating to the employment of
Executive by the Corporation not contained herein shall be of any force or
effect.

         18.  REFERENCES TO GENDER AND NUMBER TERMS. In construing this
Agreement, feminine or number pronouns shall be substituted for those masculine
in form and vice versa, and

                                      -8-

<PAGE>

plural terms shall be substituted for singular and singular for plural in any
place in which the context so requires.

         19.  COUNTERPARTS; HEADINGS; SECTIONS. This Agreement may be executed
in multiple counterparts, each of which shall be considered to have the force
and effect of any original but all of which taken together shall constitute but
one and the same instrument. The various headings in this Agreement are inserted
for convenience only and are not part of the Agreement. All references to
"Sections" and "paragraphs" in this Agreement refer to the various corresponding
sections and paragraphs of this Agreement.

         20.  SURVIVAL. The covenants and agreements contained in Sections 6
through 10 shall survive any termination or expiration of this Agreement and the
termination of Executive's employment hereunder.

         21.  ARBITRATION. Executive and the Corporation will submit any
disputes arising under this Agreement to an arbitration panel, consisting of one
or more natural persons (as set forth below) each of whom has experience
arbitrating employment disputes involving executives, conducting a binding
arbitration in Hartford, Connecticut, administered by the AAA (as defined
hereafter) and in accordance with the Commercial Arbitration Rules of the
American Arbitration Association ("AAA") in effect on the date of such
arbitration (the "Rules"), and judgment upon the award rendered by the
arbitrator or arbitrators may be entered in any court having jurisdiction
thereof; PROVIDED, HOWEVER, that nothing herein shall impair the Corporation's
right to seek equitable relief from a court of competent jurisdiction for breach
or threatened breach of Section 7 or Section 8. The award of the arbitrators
shall be final and shall be the sole and exclusive remedy between the parties
regarding any claims, counterclaims, issue or accounting presented to the
arbitration panel. The parties hereto further agree that the arbitration panel
shall consist of one (1) person mutually acceptable to the Corporation and
Executive, PROVIDED, THAT, if the parties cannot agree on an arbitrator within
fifteen (15) days of filing a notice of arbitration, the arbitration panel shall
consist of three (3) persons, one selected by the Corporation, one selected by
Executive (or his representative) and one selected by the arbitrators so
selected by the parties hereto, or if the parties hereto cannot agree, selected
by the manager of the principal office of the American Arbitration Association
in Hartford County in the State of Connecticut. All fees and expenses of the
arbitration charged by the AAA, including a transcript if either party requests,
shall be borne equally by the parties. If Executive prevails as to any material
issue presented in the arbitration, the entire cost of such proceedings
(including, without limitation, Executive's reasonable attorney's fees but
excluding the fees and expenses charged by the AAA) shall be borne by the
Corporation. If Executive does not prevail as to any material issue, each party
will pay for the fees and expenses of its own attorneys, experts, witnesses, and
preparation and presentation of proofs and post-hearing briefs (unless the party
prevails on a claim for which attorney's fees are recoverable under the Rules).
Any action to enforce or vacate the arbitrator's award shall be governed by the
federal Arbitration Act, if applicable, and otherwise by applicable state law.
If either the Corporation or Executive pursues any claim, dispute or controversy
against the other in a proceeding other than the arbitration provided for
herein, the responding party shall be entitled to dismissal or injunctive relief
regarding such action and recovery of all costs, losses and attorney's fees
related to such action.

                                      -9-

<PAGE>

                       THE NEXT PAGE IS THE SIGNATURE PAGE

                                      -10-

<PAGE>

         IN WITNESS WHEREOF, the Corporation and Executive have duly executed
this Agreement as of the day and year first above written.

                                  CORPORATION:

                                  GENAISSANCE PHARMACEUTICALS, INC.

                                  By: /s/ Kevin Rakin
                                     ----------------------------------
                                     Name: Kevin Rakin
                                     Its   Executive Vice President
                                            and Chief Financial Officer

                                  Address for Notice Purposes:
                                  5 Science Park
                                  Suite 2103
                                  New Haven, CT 06511

                                  EXECUTIVE:

                                  /s/ Gerald F. Vovis
                                  -------------------------------
                                  GERALD F. VOVIS
                                  Address for Notice Purposes:
                                  98 Prendiville Way
                                  Marlborough, MA 01752-1740

                                      -11-<PAGE>

                                                                   Exhibit 10.21

                   CONFIDENTIALITY & NONCOMPETITION AGREEMENT

         CONFIDENTIALITY & NONCOMPETITION AGREEMENT (this "Agreement"), made and
entered into as of November 16, 1999 (the "Effective Date"), by and between
GENAISSANCE PHARMACEUTICALS, INC. (the "Corporation"), a Delaware corporation
with its principal office at 5 Science Park, New Haven, Connecticut, 06511, and
RICHARD JUDSON ("Executive"), an individual who resides at 42 Barker Hill Drive,
Guilford, CT 06437.

         WHEREAS, the Corporation and Executive desire to continue their
employment relationship on the terms and conditions set forth herein;

         NOW, THEREFORE, in consideration of the mutual covenants and agreements
contained herein, and other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties agree as follows:

         1.   EMPLOYMENT. The Corporation hereby promotes Executive to Vice
President, Informatics of the Corporation, and Executive hereby accepts such
position. Executive acknowledges that this Agreement is not a contract of
employment between Executive and the Corporation and that Executive is an
employee at will of the Corporation.

         2.   COMPENSATION. As compensation for the services to be rendered by
Executive to the Corporation as Vice President, Informatics, the Corporation
shall pay Executive and provide Executive with the following compensation and
enhanced benefits which Executive agrees to accept in full satisfaction for his
services:

              a.   BASE SALARY. The Corporation shall pay Executive a Base
         Salary, payable in equal installments at such payment intervals as are
         the usual custom of the Corporation, but not less often than monthly,
         at an annual rate of $125,000, less such deductions or amounts to be
         withheld as shall be required by applicable law (the "Base Salary").

              b.   BONUSES. Hereafter, during the Executive's employment with
         the Corporation, the Corporation may pay Executive bonuses according to
         the Corporation's existing policies and at the discretion of the
         Corporation's President who shall review Executive's achievements in
         meeting the financial and performance goals of the Corporation for its
         most recent fiscal year. Each bonus, if any, shall be paid in addition
         to the Base Salary.

              c.   ENHANCED BENEFITS. Executive shall be entitled to participate
         in the Corporation's Stock Option Plan (the "Plan") and the Corporation
         shall grant Executive an option to purchase a total of 50,000 shares of
         the Corporation's common stock at an exercise price per share equal to
         $3.00 (the "Option"). The Option shall vest ratably over a 4 year
         period beginning on the date of grant of the Option. The Option shall
         be set forth

<PAGE>

         in a separate agreement embodying the grant of the Option which shall
         be otherwise in the form stipulated in the Plan.

         3.   INVENTIONS AND IMPROVEMENTS. Executive acknowledges, covenants and
agrees that the Corporation shall be the sole owner of all the fruits and
proceeds of Executive's services to the Corporation, including but not limited
to all writings, inventions, discoveries, designs, systems, processes, software
or other improvements relating to the business or products of the Corporation,
whether or not patentable, registerable, or copyrightable, which Executive may,
alone or with others, conceive, create, develop, produce or make during or as a
result of his employment with the Corporation (collectively, the "Invention"),
free and clear of any claims by Executive of any kind or character whatsoever
other than Executive's rights to compensation hereunder. Executive agrees that
he shall disclose each of the Inventions promptly and completely to the
Corporation, and shall, at the request of the President of the Corporation,
execute such assignments, certificates or other instruments as the President of
the Corporation, from time to time deems necessary or desirable to evidence,
establish, maintain, perfect, protect, enforce or defend the Corporation's
right, title and interest in or to any or all of the Inventions.

         4.   NON-DISCLOSURE OF CONFIDENTIAL INFORMATION.

              a.   Executive acknowledges that, in and as a result of his
         employment by the Corporation, he will be making use of, acquiring
         and/or adding to the Corporation's Confidential Information (as
         hereinafter defined). As a material inducement to the Corporation to
         promote Executive to Vice President, Informatics and to pay Executive
         the compensation and benefits set forth in this Agreement, Executive
         covenants and agrees that he shall not, at any time during or following
         the term of his employment with the Corporation, directly or indirectly
         divulge or disclose for any purposes whatsoever, any Confidential
         Information that has been obtained by, or disclosed to, him as a result
         of his employment with the Corporation. For purposes of this Agreement,
         "Confidential Information" means, collectively, all confidential
         matters and materials of the Corporation, including without limitation,
         the Corporation's proprietary information, inventions, trade secrets,
         knowledge, data, know-how, intellectual property, systems, procedures,
         manuals, pricing policies, operational methods and information relating
         to the Corporation's products, processes, formulae, business plans,
         marketing plans and strategies, pricing strategies, customer lists, or
         other subject matters pertaining to the business and/or financial
         affairs of the Corporation. "Confidential Information" shall not
         include any information that is in the public domain during the period
         of Executive's service to the Corporation other than as a result of
         disclosure by Executive in violation of this Agreement or any other
         agreement related to Executive's employment with the Corporation.

              b.   If Executive is required by a court of competent jurisdiction
         or other tribunal (by oral questions, interrogatories, requests for
         information or documents, subpoena, civil investigation demand or
         similar process) to disclose any Confidential Information, Executive
         may disclose such Information to such tribunal without liability
         hereunder, PROVIDED, THAT Executive first provides the Corporation with
         notice of any such

                                      -2-

<PAGE>

         requirement(s) as promptly as practicable, but in any case with
         sufficient timeliness to enable the Corporation to seek an appropriate
         protective order and/or waive its compliance with the relevant
         provisions of this Agreement.

         5.   COVENANTS AGAINST COMPETITION.

              a.   In view of the unique value to the Corporation of the
         services of Executive and because of the Confidential Information to be
         obtained by or disclosed to Executive, as herein above set forth, and
         as a material inducement to the Corporation to enter into this
         Agreement and to pay to Executive the compensation and benefits set
         forth in this Agreement, Executive covenants and agrees that during
         Executive's employment and for a period of one year after he ceases to
         be employed by the Corporation for any reason (unless the termination
         of the Executive's employment by the Corporation is without cause), he
         will not, except as otherwise authorized by this Agreement, compete in
         the field of pharmacogenomics with the Corporation or any affiliate of
         the Corporation, solicit the Corporation's customers or the customers
         of any of its affiliates in the field of pharmacogenomics, or directly
         or indirectly solicit for employment any of the Corporation's
         employees.

              b.   For the purposes of this Agreement:

                   (i)       The term "compete" means engaging in the same or
              any similar business as the Corporation or any of its affiliates
              in any manner whatsoever, including without limitation as a
              proprietor, partner, investor, shareholder, member, director,
              officer, employee, consultant, independent contractor or
              otherwise, within any geographic area in which the Corporation's
              products are offered or distributed;

                   (ii)      The term "affiliate," when used in reference to any
              Person (as hereinafter defined), means any other Person that
              directly or indirectly through one or more intermediaries
              controls, is controlled by, or is under common control with the
              first such Person; and

                   (iii)     The term "customers" means all Persons to whom the
              Corporation or any of its affiliates has provided any product or
              service, whether or not for compensation, within a period of two
              (2) years prior to the time Executive ceases to be employed by the
              Corporation.

                   (iv)      The term "cause" means material misconduct by the
              Executive or substantially inadequate performance of his duties of
              employment.

              c.   None of the provisions of this Section 5 shall prohibit
         Executive from investing in securities listed on a national securities
         exchange or actively traded over-the-counter so long as such
         investments are not greater than five percent (5%) of the outstanding
         securities of any issuer of the same class or issue.

                                      -3-

<PAGE>

         6.   REASONABLENESS OF RESTRICTIONS.

              a.   Executive has carefully read and considered the provisions of
         Section 4 and Section 5, and, having done so, agrees that:

                   (i)       The restrictions set forth in Section 4 and Section
              5, including but not limited to the time period, scope and
              geographical area of restriction, are fair and reasonable and are
              reasonably required for the protection of the good will and other
              legitimate business interests of the Corporation and its
              affiliates, officers, directors, shareholders, and other
              employees;

                   (ii)      Executive has received adequate consideration for
              such obligations; and

                   (iii)     Such obligations do not prevent Executive from
              earning a livelihood.

              b.   If, notwithstanding the foregoing, any of the provisions of
         Section 4 or Section 5 shall be held to be invalid or unenforceable,
         the remaining provisions thereof shall nevertheless continue to be
         valid and enforceable as though the invalid and unenforceable parts had
         not been included therein. If any provision of Section 4 or Section 5
         relating to the time period and/or the areas of restriction and/or
         related aspects shall be declared by a court of competent jurisdiction
         to exceed the maximum restrictiveness such court deems reasonable and
         enforceable, the time period and/or areas of restriction and/or related
         aspects deemed reasonable and enforceable by the court shall become and
         thereafter be the maximum restriction in such regard, and the
         restriction shall remain enforceable to the fullest extent deemed
         reasonable by such court.

         7.   REMEDIES FOR BREACH OF EXECUTIVE'S COVENANTS OF NON-DISCLOSURE AND
NON-COMPETITION. Executive recognizes and agrees that the Corporation's remedy
at law for any breach of Section 4 or Section 5 would be inadequate as such a
breach would cause irreparable harm to the Corporation, and he agrees that, for
breach of such provisions, the Corporation shall, in addition to such other
remedies as may be available to it at law or in equity, be entitled to
injunctive relief and to enforce its rights by an action for specific
performance.

         8.   WAIVER. A party's failure to insist on compliance or enforcement
of any provision of this Agreement shall not affect the validity or
enforceability or constitute a waiver of future enforcement of that provision or
of any other provision of this Agreement by that party or any other party.

         9.   GOVERNING LAW. This Agreement shall in all respects be subject to,
and governed by, the laws of the State of Connecticut.

         10.  SEVERABILITY. The invalidity or unenforceability of any provision
in the Agreement shall not in any way affect the validity or enforceability of
any other provision and

                                      -4-

<PAGE>

this Agreement shall be construed in all respects as if such invalid or
unenforceable provision had never been in the Agreement.

         11.  NOTICE. Any and all notices required or permitted herein shall be
in writing and shall be deemed to have been duly given (a) when delivered if
delivered personally, (b) on the fifth day following the date of deposit in the
United States mail if sent first class, postage prepaid, by certified mail, or
(c) one day after delivery to a nationally recognized overnight courier service.
The parties' respective addresses for such notices shall be those set forth
following their respective signatures below, or such other address or addresses
as either party may hereafter designate in writing to the other.

         12.  ASSIGNMENT. This Agreement, together with any amendments hereto,
shall be binding upon and shall inure to the benefit of the parties hereto and
their respective successors, assigns, heirs, executors, and legal and personal
representatives, except that the rights and benefits of Executive under this
Agreement may not be assigned without the prior written consent of the
Corporation. Without limiting the generality of the foregoing, this Agreement
shall be binding upon and inure to the benefit of any corporation with which or
into which the Corporation or its successors may be merged or which may succeed
to its assets or business.

         13.  AMENDMENTS. This Agreement may be amended at any time by mutual
consent of the parties hereto, with any such amendment to be invalid unless in
writing and signed by the Corporation and Executive.

         14.  ENTIRE AGREEMENT. This Agreement contains the entire agreement and
understanding by and between Executive and the Corporation with respect to the
subject matter hereof and supersedes all existing agreements between the
Corporation and Executive with respect to such subject matter. No
representations, promises, agreements, or understandings, written or oral,
relating to the employment of Executive by the Corporation not contained herein
shall be of any force or effect.

         15.  REFERENCES TO GENDER AND NUMBER TERMS. In construing this
Agreement, feminine or number pronouns shall be substituted for those masculine
in form and vice versa, and plural terms shall be substituted for singular and
singular for plural in any place in which the context so requires.

         16.  COUNTERPARTS; HEADINGS; SECTIONS. This Agreement may be executed
in multiple counterparts, each of which shall be considered to have the force
and effect of any original but all of which taken together shall constitute but
one and the same instrument. The various headings in this Agreement are inserted
for convenience only and are not part of the Agreement. All references to
"Sections" and "paragraphs" in this Agreement refer to the various corresponding
sections and paragraphs of this Agreement.

         17.  SURVIVAL. The covenants and agreements contained in Sections 3
through 7 shall survive any termination of Executive's employment with the
Corporation.

                                      -5-

<PAGE>

         18.  ARBITRATION. Executive and the Corporation will submit any
disputes arising under this Agreement to an arbitration panel conducting a
binding arbitration in Hartford, Connecticut, in accordance with the Commercial
Arbitration Rules of the American Arbitration Association in effect on the date
of such arbitration (the "Rules"), and judgment upon the award rendered by the
arbitrator or arbitrators may be entered in any court having jurisdiction
thereof; PROVIDED, HOWEVER, that nothing herein shall impair the Corporation's
right to seek equitable relief for breach or threatened breach of Section 4 or
Section 5. The award of the arbitrators shall be final and shall be the sole and
exclusive remedy between the parties regarding any claims, counterclaims, issue
or accounting presented to the arbitration panel. The parties hereto further
agree that the arbitration panel shall consist of one (1) person mutually
acceptable to the Corporation and Executive, PROVIDED that if the parties cannot
agree on an arbitrator within fifteen (15) days of filing a notice of
arbitration, the arbitration panel shall consist of three (3) persons, one
selected by the Corporation, one selected by Executive (or his representative)
and one selected by the arbitrators so selected by the parties hereto, or if the
parties hereto cannot agree, selected by the manager of the principal office of
the American Arbitration Association in Hartford County in the State of
Connecticut. All fees and expenses of the arbitration, including a transcript if
either party requests, shall be borne equally by the parties. Each party will
pay for the fees and expenses of its own attorneys, experts, witnesses, and
preparation and presentation of proofs and post-hearing briefs (unless the party
prevails on a claim for which attorney's fees are recoverable under the Rules).
Any action to enforce or vacate the arbitrator's award shall be governed by the
federal Arbitration Act, if applicable, and otherwise by applicable state law.
If either the Corporation or Executive pursues any claim, dispute or controversy
against the other in a proceeding other than the arbitration provided for
herein, the responding party shall be entitled to dismissal or injunctive relief
regarding such action and recovery of all costs, losses and attorney's fees
related to such action.

                       THE NEXT PAGE IS THE SIGNATURE PAGE

                                      -6-

<PAGE>

         IN WITNESS WHEREOF, the Corporation and Executive have duly executed
this Agreement as of the day and year first above written.

                                  CORPORATION:

                                  GENAISSANCE PHARMACEUTICALS, INC.

                                  By:
                                     ------------------------------
                                     Name:
                                     Its

                                  Address for Notice Purposes:
                                  5 Science Park
                                  Suite 2103
                                  New Haven, CT 06511

                                  EXECUTIVE:

                                  ----------------------------------
                                  RICHARD JUDSON
                                  Address for Notice Purposes:
                                  42 Barker Hill Road
                                  Guilford, CT 06437

                                      -7-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00008-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00008-of-00352.parquet"}]]